Cancer Clinical Trials

The knowledge to decide if cancer clinical trials and experimental treatments are right for you

Pages

  • Home
  • Book Excerpt
  • Resources
  • Clinical Trials in Cartoons
  • Audio
  • Video
  • Glossary
  • About Us
  • Contact Us

Aug 7, 2013

The West Coast Prostate Cancer Dream Team


Research Dream Team Studies Prostate Cancer Treatment Resistance from Patient Power® on Vimeo.


To put a smile on your face see Larry's latest cartoon.
To learn more about clinical trials, take a look at our book.

(c) 2012 Tom Beer and Larry Axmaker
Posted by Unknown 3 comments
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: cancer clinical trials, prostate cancer
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

OUR BOOK

A video Intro to our book - best viewed in full screen

Subscribe by email

Enter your email address:

Delivered by FeedBurner

Follow Us

Share with friends

Popular Posts

  • Gold Nanoparticle Therapy to be used in first clinical trial
  • Podcast: Drs. Armstrong and Beer discuss new prostate cancer treatments
  • Video: abiraterone and enzalutamide for advanced prostate cancer: results from ASCO 2012 discussed
  • Dr. Beer leads discussion about Advanced Prostate Cancer--Whats New in 2016 (video)?
  • More Cancer Vaccines on the Horizon
  • Guest Post: Clinical Trials Are a Perplexing Issue for Many Patients
  • Dr. Beer speaks about experimental drugs for prostate cancer
  • ASCO 2012 Update on advanced prostate cancer treatment
  • Do Placebos Really Work?
  • ASCO 2015 Prostate Cancer Updates from a Roundtable of Experts
clinicalTrials

Blogs we like

  • Women of Teal
  • My New York Minute
  • axman and prostate cancer

Search for a Cancer Clinical Trial

  • NCI Trials Search

Blog Archive

  • ►  2016 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (2)
    • ►  January (1)
  • ►  2015 (18)
    • ►  December (1)
    • ►  November (1)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (1)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (1)
    • ►  January (2)
  • ►  2014 (8)
    • ►  December (2)
    • ►  September (1)
    • ►  August (2)
    • ►  July (1)
    • ►  February (1)
    • ►  January (1)
  • ▼  2013 (15)
    • ▼  August (1)
      • The West Coast Prostate Cancer Dream Team
    • ►  June (1)
    • ►  May (1)
    • ►  April (2)
    • ►  March (3)
    • ►  February (3)
    • ►  January (4)
  • ►  2012 (67)
    • ►  December (5)
    • ►  November (4)
    • ►  October (4)
    • ►  September (5)
    • ►  August (6)
    • ►  July (5)
    • ►  June (6)
    • ►  May (7)
    • ►  April (5)
    • ►  March (4)
    • ►  February (8)
    • ►  January (8)
  • ►  2011 (3)
    • ►  December (3)

Search our blog

5-ALA abiraterone advanced prostate cancer Advances in prostate cancer treatment adverse effects alpharadin antibodies antigens ASCO aspirin awareness B-cells biopsy Blind blinded blog blogs bone cancer book brain tumor breast cancer cabazitaxel cabozantinib cancer cancer cartoons cancer clinical trials cancer costs cancer deaths cancer drugs cancer information cancer rates cancer research cancer risk cancer stages cancer survival cancer treatment Cancer vaccines canine clinical trials castration-resistant chemotherapy childhood cancer clinical trial clinical trial participation clinical trials clinical trials participation costs custirsen decision making depression DNA docetaxel double blind double blinded Dr. Lind drug approval drug control drug costs drug effectiveness drug resistance drugs elderly eligibility emotional trauma enalutamide enzalutamide enzalutimide erlotinib experiment experimental experimental drug experimental medications experimental medicine experimental meds FDA FDA approval FDA approval. FDA approved drugs funding fundraising glioma gold standard grants health insurance HER2 high costs hormonal therapy HR+ humor hypothesis Ibrance Immune system immunotherapy individualized therapy individualized treatment insurance intermittent therapy introduction killer T cells kindle leukemia low income lung cancer lymphoma magic bullet MDM2 mdv-3100 melanoma metastatic morbidity mutation myths nanoparticle therapy nanoparticles NUC-1031 OGX-011 OHSU out of pocket costs ovarian cancer p53 patient benefit Pediatric cancer personalized personalized therapy pharmacogenomics phase I Phase I study Phase II Phase III Phase IV placebo placebo effect podcast positive attitude postmenopausal prostate cancer Provenge PSA quitting a trial radiation radio randomized reading repurposed drugs resistance pathways result Russia scurvy seniors sequencing side effects significant sipuleucel-T statistics sugar pill sugar pills survival benefit table of contents TAK-700 targeted therapy telemedicine therapy too good to be true toxicity treatment treatment choices treatment resistant prostate cancer trial stages tumors under represented groups untested drug vaccines video welcome XL184 Xtandi zoledronic acid

Followers

(c) Tom Beer and Larry Axmaker 2012. Simple theme. Theme images by merrymoonmary. Powered by Blogger.